Imprivata announced the availability of Imprivata OneSign 3.5
LEXINGTON, Mass. -- Imprivata®, Inc., the enterprise authentication and access management appliance company, today announced the availability of Imprivata OneSign™ 3.5, which includes enhancements to its Single Sign-On (SSO) and Authentication Management (AM) modules. In addition to the recently announced Physical/Logical capabilities of the OneSign platform, the enhanced functionality of v3.5 ranges from a new standards-based SPML provisioning interface to a built-in RADIUS host for handling remote users that will help customers simplify access and authentication management while providing stronger, better-integrated security throughout their organizations.
Moffitt Cancer Center, located on the University of South Florida campus, is taking advantage of the new SPML provisioning interface to connect OneSign 3.5 with Moffitt’s provisioning system, AccountCourier from Courion, to strengthen its cross-organization security while ensuring employee productivity. “Imprivata’s OneSign solutions will be instrumental in our organization’s security infrastructure,” said Edward Martinez, VP & Chief Information Officer at Moffitt Cancer Center. “The flexibility of its appliance and the standards-based provisioning interface of OneSign 3.5 allows us to cost-effectively integrate access and authentication management—and enables us to do so without replacing the process our employees are comfortable with and use everyday.”
About the Author(s)
You May Also Like
Beyond Spam Filters and Firewalls: Preventing Business Email Compromises in the Modern Enterprise
April 30, 2024Key Findings from the State of AppSec Report 2024
May 7, 2024Is AI Identifying Threats to Your Network?
May 14, 2024Where and Why Threat Intelligence Makes Sense for Your Enterprise Security Strategy
May 15, 2024Safeguarding Political Campaigns: Defending Against Mass Phishing Attacks
May 16, 2024
Black Hat USA - August 3-8 - Learn More
August 3, 2024Cybersecurity's Hottest New Technologies: What You Need To Know
March 21, 2024